Research Article
Pediatrics Infected with COVID-19: A Case Series Study on Pediatrics Hospitalized in a Referral Pediatric Hospital
| | Variable | Mean (SD) or . (%) |
| | Blood test | White blood cells (×103/ml) | 8460 (6438) | | Lymphocytes (×103/ml) | 28 (19.63) | | Polymorphonuclear leukocytes (×109/L) | 64 (19.31) | | Hemoglobin (g/L) | 12.33 (5.54) | | Platelet count (×109/L) | 152290 (78030.48) | | Blood urea nitrogen (mg/dL) | 24 (4796) | | Creatinine (mg/dL) | 0.97 (0.99) | | Blood potassium level (mmol/L) | 4.57 (1.14) | | Blood sodium levels (mmol/L) | 131.84 (30.53) | | Blood calcium levels (mg/dL) | 8.55 (1.56) | | Prothrombin time (s) | 14.55 (1.46) | | Activated partial thromboplastin time (s) | 37.5 (9.16) | | Creatine phosphokinase (U/L) | 190.67 (162.58) | | Decrease | 1 (33) | | Normal | 2 (66) | | Lactic acid dehydrogenase (U/L) | 698.71 (336.18) | | Increase | 3 (42) | | Normal | 4 (57) | | Alanine aminotransferase (U/L) | 28.08 (21.1) | | 11 (92) | | >45 | 1 (8.3) | | Aspartate aminotransferase(IU/L) | 46.33 (24.21) | | 8 (67) | | >45 | 4 (34) | | Bilirubin direct (mg/dl) | 0.9 (0.84) | | 0 | | >0.2 | 2 (100) | | Bilirubin total μmol/L | 1.65 (0.77) | | 0 | | >1.2 | 2 (100) |
| | RT-PCR | Positive/negative | 17/4 (81/20) |
| | ABG | PH (7.35-7.45) | 7.32 (0.11) | | Increase | 9 (53) | | Decrease | 5 (29.4) | | Normal | 2 (18) | | PaCo2 (32-48 mmHg) | 38.91 (8.57) | | Increase | 3 (17.6) | | Decrease | 2 (11.8) | | Normal | 12 (70.6) | | Pao2 (83-108 mmHg) | 72.80 (28.92) | | Increase | 1 (5.9) | | Decrease | 8 (47) | | Normal | 8 (47) | | HCo3 (20-28 mEq/L) | 20.52 (5.17) | | Increase | 5 (29.4) | | Decrease | 1 (5.9) | | Normal | 11 (64.7) | | Base excess | -2.31 (12.01) |
|
|
